KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Gains from Investment Securities (2020 - 2025)

Hims & Hers Health's Gains from Investment Securities history spans 6 years, with the latest figure at $6000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 100.28% year-over-year to $6000.0; the TTM value through Dec 2025 reached $2.1 million, up 3712.5%, while the annual FY2025 figure was $2.1 million, 3712.5% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $6000.0 at Hims & Hers Health, down from $814000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $25.7 million in Q1 2025 and bottomed at -$24.4 million in Q2 2025.
  • The 5-year median for Gains from Investment Securities is $404000.0 (2022), against an average of $960470.6.
  • The largest YoY upside for Gains from Investment Securities was 5412.19% in 2025 against a maximum downside of 4694.35% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $457000.0 in 2021, then crashed by 621.01% to -$2.4 million in 2022, then surged by 667.2% to $13.5 million in 2023, then plummeted by 115.68% to -$2.1 million in 2024, then surged by 100.28% to $6000.0 in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Gains from Investment Securities are $6000.0 (Q4 2025), $814000.0 (Q3 2025), and -$24.4 million (Q2 2025).